AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Redcare Pharmacy NV still sees FY adj. EBITDA margin 2% to 2.5%
ByAinvest
Tuesday, Jul 29, 2025 12:31 am ET1min read
Redcare Pharmacy NV still sees FY adj. EBITDA margin 2% to 2.5%
Redcare Pharmacy NV (ETR:RDC), an online pharmacy operator in Europe, has forecasted its FY adj. EBITDA margin to range between 2% and 2.5% for the fiscal year 2025. This projection follows a period of growth and expansion, as the company has been expanding its presence in various European markets and investing in technology-driven efficiencies.The company's forecast is based on its recent earnings and revenue performance, which have shown signs of improvement. For instance, the company's earnings per share (EPS) were upgraded to €0.64 loss in May 2025 [1]. Additionally, the company's revenue has been growing, with the first quarter 2025 earnings released in May 2025 [2].
However, the company's debt levels have been a concern for some investors. The company's debt-to-equity ratio stands at 50%, which is relatively high compared to its peers [3]. Despite this, the company's management has stated that it can afford some debt, citing its strong cash flows and growth prospects [4].
The company's share price has been volatile over the past year, with a weekly volatility of 8% compared to the German market average of 75% [5]. This volatility has led to some investors expressing concern about the company's share price stability [6].
Overall, Redcare Pharmacy NV's forecast for a FY adj. EBITDA margin between 2% and 2.5% is a reflection of its ongoing efforts to improve its financial performance and expand its market presence. However, investors should continue to monitor the company's debt levels and share price volatility.
References:
[1] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
[2] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
[3] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
[4] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
[5] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
[6] https://simplywall.st/stocks/de/consumer-retailing/etr-rdc/redcare-pharmacy-shares
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet